patients with wild type EGFR, meaning there is no EGFR mutation,
drugs like Tarceva (erlotinib) can have a small benefit, but Dr.
Joan Schiller wants research to do better. February 2014
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.